Novo Nordisk continues to fight to acquire American biotech company. (Archive photo). Photo: Mads Claus Rasmussen/Ritzau Scanpix
Novo Nordisk raises its bid for sought-after obesity drug
In the ongoing bidding war for biotech company Metsera, Novo Nordisk has reportedly outbid Pfizer. Initially, Pfizer matched Novo’s previous offer of $10 billion. Novo then made a higher bid, emphasizing that their offer is currently the highest. Novo Nordisk CEO Mike Doustdar announced that...
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?